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Abstract
Background: Heterologous expression of psychrophilic enzymes in E. coli is particularly challenging due to their
intrinsic instability. The low stability is regarded as a consequence of adaptation that allow them to function at low
temperatures. Recombinant production presents a significant barrier to their exploitation for commercial
applications in industry.
Methods: As part of an enzyme discovery project we have investigated the utility of a cold-shock inducible
promoter for low-temperature expression of five diverse genes derived from the metagenomes of marine Arctic
sediments. After evaluation of their production, we further optimized for soluble production by building a vector
suite from which the environmental genes could be expressed as fusions with solubility tags.
Results: We found that the low-temperature optimized system produced high expression levels for all putatively
cold-active proteins, as well as reducing host toxicity for several candidates. As a proof of concept, activity assays
with one of the candidates, a putative chitinase, showed that functional protein was obtained using the low-
temperature optimized vector suite.
Conclusions: We conclude that a cold-shock inducible system is advantageous for the heterologous expression of
psychrophilic proteins, and may also be useful for expression of toxic mesophilic and thermophilic proteins where
properties of the proteins are deleterious to the host cell growth.
Keywords: cspA promoter, Heterologous expression, Fusion partner, Restriction-free cloning, Cold-adapted,
Metagenomic DNA
Background
Enzymes used in industry often originate from extremo-
philic organisms to fit the operating conditions for bioca-
talysis required by the process [1, 2]. These enzymes have
evolved to function in ecological niches that may include
very low or very high temperature, extreme pH, high salt
concentration or high pressure. Recombinant production
of some of these enzymes presents a significant challenge
for their use in biotechnology and industry due to the
demands of these applications for large amounts of highly
pure protein [2, 3]. This is particularly relevant in the case
of cold-adapted (psychrophilic) enzymes [4, 5] as the
intrinsic instability of these proteins, which is a conse-
quence of adaptations that allow them to function at low
temperatures, makes them more challenging to produce
than their mesophilic and thermophilic homologues
(reviewed in [6, 7]). Little attention has been given to
heterologous expression of psychrophilic enzymes, despite
their large range of technological applications and com-
mercial value (reviewed in [8]). In this study, we present a
vector suite designed to optimize E. coli-based expression
of putatively cold-adapted proteins which are encoded by
genes sourced from the marine Arctic environment. We
have opted to control the expression of our recombinant
proteins by a cold-shock inducible promoter, the E. coli
cold-shock protein A (cspA) promoter [9, 10]. This pro-
moter drives high levels of protein expression, comparable
to the commonly used T7-system, but is induced by a
downshift in temperature rather than addition of an
exogenous chemical inducer [9, 10]. In addition, we have
utilized several well-documented solubilization tags, such
as the maltose-binding protein (MBP) [11–13], the nas-
cent chain chaperone trigger factor (TF) [14, 15], E. coli
thioredoxin (TRX) [16] and small ubiquitin-like modifier
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(SUMO) [17] as fusion partners to our candidate proteins,
combined with the hexahistidine-tag (His) for purification
[18–21]. Using a restriction-free (RF) cloning method
[22, 23], we have built up a suite of vectors encoding
these fusion partners, based on the pCold-II vector that
encodes the cspA promoter [24]. This vector suite facili-
tates the parallel testing of several important factors for
recombinant expression, solubility and functionality of
putatively cold-active enzymes encoded by environmen-
tal genes of Arctic origin.
Methods
Origins and cloning of candidate genes
The genes used in this study are part of a large biopros-
pecting project (the Norwegian MARZymes initiative),
which aims to discover and develop commercially useful,
cold-active enzymes sourced from the Arctic environ-
ment. Fosmid libraries were generated from metagenomic
DNA purified from two sediment samples that were
collected from either the sea floor of the Barents Sea
(candidates MZ0003, MZ0009, MZ0012, MZ0013), or the
intertidal zone at Kapp Wijk, Svalbard (MZ0047). The
details of library preparation are outside of the scope of
this publication, and in the case of the Kapp Wijk sample
are described elsewhere [25]. The Fosmid inserts were
sequenced using 454 technology [26], and the relevant
gene sequences have been deposited to the European
Nucleotide Archive [ENA: LM651246, LM651247,
LM651248, LM651249 and LM651250]. Open reading
frames were found in the Fosmid sequences using the
MetaGeneMark prediction tool [27]. Gene candidates and
putative activities were identified based on homology
searches using t-BLAST [28]. Sequences were analyzed for
the presence of signal peptides, which would target traf-
ficking across the cytoplasmic membrane in the native
host, by the SignalP 4.1 server [29] using the default cutoff
values. Both Gram-positive and Gram-negative organism
settings were run as the species these genes originate from
are unknown. Domain information was assigned using the
Pfam database with a threshold E-value of 1.0 [30]. Struc-
tural homologues and predicted tertiary structures were
analyzed using the homology modeling software SWISS-
MODEL [31] in the ‘automodel’ mode. The molecular
weight and pI were calculated using the ProtParam tool at
the ExPASy server [32].
The candidate genes described in this paper represent
a sub-set of ‘difficult’ targets from the bioprospecting
project, which had previously failed in recombinant
expression trials using T7-based promoter systems. Pre-
viously, the genes were cloned as constructs with a var-
iety of truncations, signal sequences or fusion tags and
then expressed in various cell strains at different tem-
peratures in attempts to obtain sufficient amounts of
soluble product for characterization (Additional file 1:
Table S1–S3). Truncations were designed to express in-
dividual fragments or domains annotated from Pfam or
trimmed to remove predicted signal peptides. The rea-
sons for failed expression included insoluble production
as inclusion bodies or toxicity resulting in death of the
expression cultures (Additional file 1: Table S1–S3).
Sub-cloning of genes into the pCold-II-based vectors
was done by RF-cloning [22, 23], as described below.
Several of the candidates were truncated based on the
above-mentioned bioinformatic analyses of the sequences,
our previous examples of successful T7-based expression
(Additional file 1: Table S1–S3), and on the observation
that N-terminal and C-terminal truncations can reduce
flexibility and increase stability [33]. The regions cloned
are listed in Table 1.
Construction of a pCold-II vector suite
To enable tag-removal at a later stage of purification, a
Tobacco Etch Virus (TEV) protease site was introduced to
the pCold-II vector (Takara) by annealed oligonucleotide
cloning. 50 μM of each of the oligonucleotides TEV5’
and TEV3’ (Additional file 1: Table S4) were hybridized
at 95 °C for 5 min, and cooled to 4 °C. 0.75 μM of the
annealed oligos were phosphorylated by 10 U T4 poly-
nucleotide kinase (NEB) in T4 kinase buffer supple-
mented with 1 mM ATP (Sigma). After stopping the
reaction with 20 mM EDTA, 0.5 pmols annealed oligos
were ligated in a 1:10 ratio of oligos to BamHI (NEB)
and CIAP (Finnzymes) treated pCold-II vector, using
T4 DNA ligase (NEB). Vectors encoding different fusion
partners were generated by introducing genes for the solu-
bility tags between the existing His-tag and TEV site of the
pCold-II-TEV vector using RF-cloning [22, 23, 34]. Genes
encoding the TRX-, MBP-, TF- and SUMO-tags were amp-
lified from templates using the primers listed in Additional
file 1: Table S4 that were designed using an online tool de-
scribed in [35]. The E. coli trx gene encoding residues
2–109 of TRX [UniProt: P0AA25] was amplified from
pET32a(+) (Novagen). The E. coli malE gene encoding
residues 27–391 of MBP [UniProt: P0AEX9] was amp-
lified from pHMGWA [36]. Genomic DNA isolated from
a DH5α strain was template for the E. coli tig gene encod-
ing residues 2–432 of TF [UniProt: B7UJQ9] and a codon-
optimized yeast smt3 gene (GenScript) served as template
for SUMO [UniProt: Q12306] encoding resides 2–98. The
megaprimers containing fusion partner genes were ampli-
fied using Phusion polymerase (Finnzymes), purified with
the QIAquick PCR purification kit (Qiagen) and inserted
in the vector by linear plasmid amplification. To remove
parental DNA, the PCR products were digested with 20 U
DpnI (NEB) and transformed to E. coli XL1blue cells by
conventional heat shock. Sanger sequencing was used to
confirm correct cloning of all vectors. Information about
the vectors used in this study is summarized in Table 2.
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Table 1 Summary of in silico analysis and cloning information of candidate sequences
Candidate Putative activity tBlast homologue (% identity)a PDB homologue (residue












MZ0003 Carbohydrate esterase Family 15 Acetyl xylan esterase
Planctomyces maris (57)
3picB (39–430, 20.8) 6 N/Y(25–26) 48/46 LM651246
MZ0009 Glycosyl hydrolases family 18 Glycoside hydrolase Herpetosiphon
aurantiacus DSM 785 (26)
3g6mA (27–358, 23.0) 12 N/Y(28–29) 48/36 LM651247
MZ0012 Glycosyl hydrolases family 39 β-xylosidase Mycobacterium
abscessus (42)
4ekjA (65–358, 26.3) 13 N/N 42/42 LM651248
MZ0013 Carbohydrate esterase Family 4 Polysaccharide deacetylase
Halorhodospira halophila SL1 (64)
3vus2A (31–259, 26.4) 6 Y/Y(30–31) 39/21 LM651249
MZ0047 ATP dependent DNA ligase ATP dependent DNA ligase
Marinobacter adhaerens HP15 (70)
4d05A (39–287, 46.6) 8 Y(33–34)/Y(31–32) 32/29 LM651250
aBased on Pfam and NCBI conserved domain annotations and BLAST homology
bDetermined from SwissModel structure homology














Insertion of candidate genes into the pCold-II vector suite
To introduce candidate genes into the panel of pCold-II
vectors, megaprimers of each candidate were generated
by PCR and then inserted into vectors by RF-cloning as
described above. Clone selection was carried out by PCR
screening of single colonies using a Taq DNA polymer-
ase master mix (Ampliqon). Plasmids were isolated
using the Wizard plasmid purification kit (Promega),
and Sanger sequencing confirmed successful insertions
of sequences to vectors.
Recombinant protein expression
Recombinant proteins were expressed in 24 deep well
plates (DW24) according to the protocol described in
[37]. Plasmids were transformed into the E. coli host
strains, Rosetta2(DE3)pLysS, BL21CodonPlus(DE3)RIL
or ArcticExpress(DE3)RIL by heat shock. Cells were
grown in 4 ml 2YT medium supplemented with 2 % (w/v)
D-glucose and relevant antibiotics (100 μg/ml ampicillin,
25 μg/ml kanamycin, 12.5 μg/ml tetracycline, 20 μg/ml
gentamycin and/or 34 μg/ml chloramphenicol) at 37 °C in
a Micro-Expression Plate Shaker (GlasCol) at 450 rpm for
2–4 h until cells reached optical density at 600 nm
(OD600) of 0.5–0.9. Recombinant expression was induced
by a temperature downshift to 15 °C and addition of
0.4 mM IPTG. After 16–20 h cells were harvested by
centrifugation and resuspended in 1 ml of 50 mM
TrisHCl pH 8.0, 250 mM NaCl, 1x cOmplete protease
inhibitor cocktail (Roche) and lysed by three 5 s pulses
at 25 % amplitude on VibraCell sonicator (Sonics) with
a 3 mm microtip. Samples collected before and after a
centrifugation at 3461 x g for 30 min were analyzed on
4–20 % MiniProtean TGX precast SDS-PAGE gels
(BioRad) to determine the total amounts of induced
and soluble protein, respectively. Successful expression
of recombinant protein was assessed as the presence of
a band in the post-induction sample at the molecular
weight predicted by its primary sequence, and was
scored on a qualitative scale from 0 to 3: 0, no visible
recombinant protein; 1, visible recombinant protein at
similar levels as endogenous host proteins (<10 % of
total); 2, visible recombinant protein at higher levels
than endogenous host proteins (≈10–50 % of total); and
3, visible recombinant protein at very high levels
(>50 % of total). Failure of the cells to grow after trans-
formation was taken as a sign of toxicity, and these
samples were assigned a score of −1. To determine the
solubility of recombinant proteins, the density of the
protein bands was quantified by integration of the band
intensity to area from SDS-PAGE gels after Coomassie
staining using the QuantityOne software (BioRad) and
normalized to the culture OD600 at harvest to correct
for different growth rates. Solubility was calculated as a
percentage of the total expression yield after subtrac-
tion of background intensity.
Chitinase assay
To measure chitinase activity, a fluorometric assay (Sigma)
was performed according to the manufacturer’s instruc-
tions. Activity from 10 μl of crude extract was assayed
with 0.72 μg substrate in 0.1 M Na2HPO4 at 20 °C in
100 μl final volume. Three different chemicals, all labeled
with 4-methylumbelliferone (4MU), 4MU-N-acetyl-β-D-
glucosaminide, 4MU-N,N’-diacetyl-β-D-chitobioside and
4MU-β-D-N,N’,N”-triacetylchitotriose, were used as sub-
strate analogs of chitin. Reactions were stopped with 1 M
alkaline sodium carbonate. The release of fluorometric
4MU was measured using an excitation wavelength of
360 nm and emission wavelength of 450 nm in a Spec-
troMax microplate reader (Molecular Devices). The
background fluorescence intensities (relative values)
were subtracted form the experimental values, which
were then normalized to the semi-quantitative measure
of soluble protein (as explained above). A chitinase extract
from Trichoderma viride (Sigma) was used as a positive
control.
Results and discussion
Selection of candidates and rationale for their
recombinant expression
The genes tested in this study are part of a bioprospecting
project that aims to discover new enzymes with potential
Table 2 Expression vectors used in this study
Vector Fusion partners Fusion partner size (kDa)a Promoter Linker (aa)b Resistance gene Manufacturer
pCold-II His n.d. cspA - bla Takara
pCold-II-TEV His 3 cspA 16 bla This study
pCold-II-TRX-TEV His, TRX 15 cspA 11 bla This study
pCold-II-MBP-TEV His, MBP 43 cspA 11 bla This study
pCold-II-SUMO His, SUMO 13 cspA 0 bla This study
pCold-II-TF-TEV His, TF 51 cspA 12 bla This study
an.d. not determined (not relevant for this work)
bGiven as the region from the His-tag to the start of candidate sequence insertion site, including the TEV site (7 aa)
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commercial applications, and includes two putative carbo-
hydrate esterases, two putative glycosyl hydrolases and a
putative ATP-dependent DNA ligase. All genes originate
from metagenomic DNA that was purified from marine
Arctic sediment samples. Candidate genes with sequence
homology to proteins of known activity were selected
based on tBLAST searches of open reading frames [28]
and Pfam domain assignments [30] (Fig. 1, Table 1). Four
of the candidates have probable extracellular locations
in the native hosts based on the prediction of leader
peptides, and three candidates encode two or more
cysteine residues in their native polypeptide, some of
which could be involved in forming disulfide bonds in
the folded structures. The mature proteins have pre-
dicted isoelectric points ranging from 4.4 to 9.9, one or
two separate domains (for MZ0003 there was no domain
prediction), and masses from 32 to 48 kDa. In some cases
only portions of the genes were expressed to remove
signal peptides, to express only annotated Pfam domains,
or to minimize the numbers of low complexity regions
and hydrophobic patches in an attempt to improve solu-
bility (Fig. 1). Our candidates are typical representatives of
enzyme discovery projects, which cover a set of sequences
with diverse properties. Because the DNA was sourced
from a permanently cold environment, we presume these
genes derive from cold-adapted organisms and wanted
to ensure low-temperature expression conditions for the
recombinant protein products. The challenge was how to
efficiently produce such varied and challenging enzymes
in an optimal but universal way, with an acceptable yield
and throughput. We decided to use E. coli as a host for
expression, although this host is known to have lower
growth rates and less efficient protein production at low
temperatures [38, 39]. To compensate for this, we tested
the commercial pCold-II vector [24], and utilized its cspA
promoter to direct high levels of cold-shock induced
expression in E. coli. The cspA 5′UTR region, which is
included in the promoter region of the vector (Fig. 2),
adopts a highly stable structure allowing for efficient
protein synthesis at low temperatures, such as 15 °C [9,
40–43]. Basal expression from the cspA promoter is
repressed by a constitutively expressed LacI repressor
protein that binds the lac operator [24], and a 5′UTR
that contains a sequence that traps translation of the re-
combinant protein and enhances its translation [44–46]
(Fig. 2). The pCold-II vector encodes an N-terminal
His-tag for purification; so to allow its removal after
expression we introduced a TEV protease cleavage site
into the multiple cloning site of pCold-II (Fig. 2,
Table 2). The genes from our five candidates where suc-
cessfully inserted into the vector using the RF-cloning
method [22, 23, 34].
The cspA promoter gave high total expression and some
soluble protein for all candidates
In initial E. coli screens, T7 promoter-driven expression
of the five candidates caused problems with insolubility
and toxicity (Additional file 1: Tables S1–S3).
To evaluate the performance of the cspA promoter for
production of our metagenomic proteins, recombinant
expression was tested in three common expression strains:
BL21CodonPlus(DE3)RIL, ArcticExpress(DE3)RIL and Roset-
ta2(DE3)pLysS (Fig. 3a). All these strains contain genes
encoding rare tRNAs to compensate for the codon usage
bias in the Arctic-sourced genes (Table 1) [47–49]. In
addition, the strain ArcticExpress(DE3) co-expresses
cold-active chaperonines, Cpn60 and Cpn10 from
Oleispira antarctic, which impart an active protein
folding system at low temperatures and is expected to
be advantageous for expression of psychrophilic proteins
Fig. 1 Environmental candidate sequences. Cartoon of the sequences of all candidates annotated with leader sequences (black boxes) and
predicted Pfam domains (white boxes, borders are given by residue number), drawn to scale. No Pfam domain predictions were found for
MZ0003. The presence of known catalytic residues and cysteines is highlighted with black and white circles, respectively. The length of native
proteins are given next to each candidate, and cloned regions are indicated with arrowed lines
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[50]. Successful expression of recombinant proteins, iden-
tified from their size on SDS-PAGE, was scored according
to the qualitative scale from −1 to 3 described in the
Methods section. We found cspA drove high expression
levels for all candidate proteins in at least one of the
strains tested. Interestingly, none of the candidates had
negative effects on cell viability, either during transform-
ation, from inoculation to log phase grown or after induc-
tion of protein expression (Fig. 3a). Consequently, we
were able to express candidate proteins in all strains, in-
cluding the ArcticExpress(DE3)RIL strain which had pre-
viously been unusable in combination with several targets
(MZ0003, MZ00013 and MZ0047) under T7-driven ex-
pression (Tables S1-S3). The explanations for this have not
been elucidated; however, our data is consistent with a re-
cent report where combining the cspA promoter system
with ArcticExpress was successful for expression of cold-
adapted proteins [51] and expands the repertoire of ex-
pression strains that can be used for these, and most likely
other, candidate proteins.
The proportion of recombinant protein in the soluble
fraction was evaluated for all candidates expressed under
cspA in the BL21CodonPlus(DE3)RIL expression strain,
according to a semi-quantitative scale. All candidates were
expressed in the soluble fraction with a proportion of
approximately 10 % or lower compared to the total ex-
pression yield (Fig. 3b). Our data is consistent with
previous publications reporting that the pCold-vectors
can facilitate soluble expression [24, 52, 53] although
the extent of solubility depends on the particular protein
being expressed.
While the solubility of these candidates expressed in the
cspA system was not dramatic, this may still be of import-
ance for particular poorly expressed proteins where T7
does not appear to be a viable option; as in the cases of
MZ0009 and MZ0047 where complete insolubility and
toxicity had previously precluded recombinant production
of these targets (Additional file 1: Table S1–S3).
Building a cold-shock inducible vector suite encoding
fusion partners
As the final yields of soluble protein were still not suffi-
cient for up-scaling for most of our candidates, we were
inspired by previous findings [52, 53] to fuse established
solubility partners to our recombinant proteins in an at-
tempt to improve their solubility (Fig. 4). We selected the
small, soluble protein TRX [16], the large, highly soluble
MBP [11–13], and two proteins that have not previously
been used in combination with the cspA system: the
ubiquitin-like SUMO protein [17] and the co-chaperone
TF [14, 15], to be used as fusion partners. Previously, these
partners have proved successful for soluble expression in
large and systematic studies [54–56]. The vector suite was
designed to facilitate an efficient and parallel cloning
workflow of candidates as fusions to partners. Only three
primers per candidate are required to clone each candi-
date gene into the vector suite: one forward primer to gen-
erate the His, His-TRX, His-MBP and His-TF fusion
constructs, a second forward primer for the SUMO
fusion constructs required to engineer the immediate
transition from SUMO-tag to candidate protein, and a
reverse primer which was used for all five (Additional
file 1: Table S4). Complementing a recent report [57],
we demonstrated the application of RF-cloning in
building a tailored vector suite and enabling parallel
cloning of candidate sequences. All vectors were tested
in the E. coli Rosetta2(DE3)pLysS strain for soluble
expression of fusion partners without candidate genes,
and as expected, the majority of recombinant proteins
were soluble (data not shown).
Improvement in solubility with several fusion partners
Small-scale expression of all five candidates from the
pCold-II-based vector suite gave significant amounts of re-
combinant protein, with the exception of the TRX fusion
constructs (Table 3). To evaluate the solubility of each
candidate expressed from the vector suite, we inspected
Fig. 2 Cloning and expression region of pCold-II-TEV. The cold-shock protein A promoter (cspA), the lac operator, ribosome binding site
(RBS) and the translation-enhancing element (TEE) regulate gene expression from pCold-based vectors. The cspA-derived 5′UTR region allows
low-temperature induction as it is stable at temperatures around 15 °C, but highly unstable at 37 °C. A TEV protease recognition sequence was
introduced at the BamHI restriction site of the cloning region of pCold-II to allow removal of the vector-encoded His-tag from recombinant
proteins. The cartoon is drawn to scale
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the SDS-PAGE results of cleared lysates relative to the
total yields of recombinant protein produced using the
qualitative scores described above. As the His-tag alone
does not aid solubility, this construct served as a reference
for comparing the improvement in solubility imparted by
the fusion partners. We found that the large fusion part-
ners His-MBP and His-TF cloned N-terminal to the can-
didates gave an outstanding improvement in solubility
compared to the His-TRX- and His-SUMO-tags (Table 3).
This is in line with previous reports where MBP exceeds
smaller tags for soluble expression of both psychrophilic
and mesophilic prokaryotic proteins using T7-driven [58]
and cspA-driven expression vectors [53]. Several studies
have also been conducted on yeast, plant, mammalian and
insect proteins showing a similar performance of MBP
[13, 53, 59]. His-TRX-fusion proteins had varying expres-
sion levels between independent experiments, and for
some constructs (MZ0003, MZ0009 and MZ0047) cell
viability was negatively impacted during transformation.
Previous findings have shown that the TRX-tag does not
work consistently in combination with the pCold system
[53]; however as we found that the pCold-II-TRX-TEV
vector gave soluble expression of the tag alone, an explan-
ation for the observed toxic effect in our system has not
been elucidated.
To summarize, we found that fusion tags, in particular
MBP and TF, can be successfully utilized to improve
solubility of putatively cold-active enzymes. For all can-
didates tested in this study, at least one condition was
identified which gave rise to sufficient levels of soluble
fusion protein to make further attempts at recombinant
production feasible.
Using the vector suite, a functional chitinase was produced
As a proof of principle, the candidate MZ0009 was chosen
for functional investigation. This candidate showed a
marked improvement in expression under the cspA
promoter in Rosetta2(DE3)pLysS; previous T7-based ex-
periments resulted in completely insoluble protein (Tables
S1-S3), while cspA-controlled expression produced 5-10 %
soluble product with only a His-tag (Fig. 3b), which in-
creased to 80-100 % when His-MBP- and His-TF-tags
were used (Table 3). Semi-quantitative evaluation of
MZ0009 solubility with different tags showed an im-
provement in the order: TF >MBP > SUMO =His
(Fig. 5a and b). The two latter tags show considerable
variation in solubility between parallel experiments, and
were therefore considered equal. As described above, no
transformants were obtained when MZ0009 was cloned
in fusion with the His-TRX-tag.
Based on amino acid sequence similarity, the MZ0009
candidate was annotated as a chitinase belonging to the
glycoside hydrolase family 18 (GH18) [60, 61]. This class
of enzymes hydrolyze the glycosidic β-1,4-linkage between
Fig. 3 Heterologous expression of candidate genes driven by the
cspA promoter. a cspA promoter driven heterologous expression
of candidate proteins in three E. coli expression strains;
BL21CodonPlus(DE3)RIL (light grey bars), ArcticExpress(DE3)RIL
(medium grey bars) and Rosetta2(DE3)pLysS (black bars). A
qualitative scale for scoring expression success was used as
described in the main text. b Normalized protein expression (upper
panel) and solubility (lower panel) of candidates after cspA driven
expression in BL21CodonPlus(DE3)RIL. Error bars show the standard
deviation between two independent experiments
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N-acetylglucosamine (GlcNAc) units of the chitin biopoly-
mer, and can be endo- and exo-acting [62–65]. A puta-
tively cold-adapted chitinase of the GH18-family is
industrially relevant for treatment of chitin-rich bio-
mass at low temperatures, for biocontrol of phytopatho-
gens in cold environments and prevention of microbial
spoilage of refrigerated food [64, 66–68].
The conserved catalytic DxDxE motif [69, 70] was
found in MZ0009 based on an alignment of the
MZ0009 sequence with characterized GH18 chitinases
(Additional file 2: Figure S1). The motif includes the
essential, catalytic residues asp147, asp149 and glu151,
corresponding to asp140, asp142 and glu144 respectively
in the well-characterized ChiB from Serratia marcescens
[71–73]. To confirm this sequence annotation, clarified
lysates containing MZ0009 fused to each of the four tags
were assayed for chitinase activity (Fig. 5c) using three
synthetic 4-methylumbelliferone (4MU)-labeled chitin an-
alogs. The His-, His-MBP- and His-SUMO-tagged fusion-
constructs of MZ0009 displayed pronounced chitinolytic
activity on the 4MU-β-D-N,N’,N”-triacetylchitotriose (4MU-
(GlcNAc)3) substrate (Fig. 5c), while lower levels of chiti-
nase activity were detected on the 4MU-N,N’-diacetyl-
β-D-chitobioside (4MU-(GlcNAc)2) substrate with the
His-SUMO and His-MBP constructs (Fig. 5c). As exo-
chitinolytic enzymes act on terminal N-acetylglucosamine
residues to remove either monosaccharides or disaccha-
rides, endochitinases are required to release fluorescent
products from 4MU-(GlcNAc)3 [74], indicating that
MZ0009 is an endochitinase. Interestingly the His-SUMO-
fusion construct, which gave little or no improvement in
solubility compared to the His-only construct (Fig. 5a and
b), showed the most pronounced chitinolytic activity
(Fig. 5c). This indicates that soluble expression, which
was equivalent for both constructs, does not necessarily
equate to a functional enzyme, as the His-tagged control
was significantly less active than the His-SUMO fusion.
As none of the solubility tags had chitinolytic activity when
expressed alone (data not shown) this improvement in
activity can only be ascribed to an influence of the fusion
partner on MZ0009 folding. Our data strengthens the ob-
servation that MBP and SUMO partners can be used to
promote correct folding of difficult-to-express proteins [58,
75]. In addition to confirming the successful folding of the
MZ0009 fusion constructs, we have provided a preliminary
characterization of an endo-chitinase. As a proof of
concept, a functional chitinase, representing the first re-
combinant endo-chitinase from an environmental Arctic
source was produced by using the cold-shock inducible
vector suite.
Although approximately 80 % of the His-TF fusion
construct of MZ0009 was expressed as a soluble protein,
Table 3 Semi-quantitative analysis of fusion construct expression and solubility in Rosetta2(DE3)pLysSa
Target size (kDa) Mean Expression Mean Solubility
Candidate Native Recombinant His His-SUMO His-TRX His-MBP His-TF His His-SUMO His-TRX His-MBP His-TF
MZ0003 48 45.6 3 3 0.5 3 3 1 0.5 1 1.5 3
MZ0009 48 35.8 3 3 −1 3 3 1 1 0 2 3
MZ0012 42 41.6 3 3 2.5 3 3 0.5 0.5 0.5 1.5 3
MZ0013 39 21 3 3 2.5 3 3 1 1.5 1 3 3
MZ0047 32 28.9 2 2.5 1.5 2.5 3 1 0.5 1 2 3
aevaluated in two independent experiments by a qualitative scoring system described in the text
Fig. 4 Cartoon of fusion-proteins expressed from the cold-inducible vector suite. Cartoon of the affinity tag (black box) and solubility tags (light
grey box) in fusion to candidate sequences (dark grey box) in the recombinant constructs that were generated in this study. Fusion partners are
removable in all constructs either by TEV or SUMO protease cleavage; their recognition sites are indicated by triangles. Fusion partners are drawn
to scale
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this fusion construct has no significant activity towards
4MU-(GlcNAc)3 in our chitinolytic assay (Fig. 5c). We
attempted to remove the His-TF-tag utilizing the TEV-
protease site between the tag and candidate (Fig. 2), but
TEV protease treatment in a cleared lysate resulted in
only approximately 10 % cleavage of the fusion protein
(data not shown), which may indicate that the TEV-site
in the linker (Table 2) was inaccessible to the TEV prote-
ase. A known drawback of fusion tags is they may inter-
fere with the activity of the candidate protein by sterically
hindering access of substrate to the catalytic site, or by
causing the candidate to adopt a non-functional, though
soluble, conformation [76, 77]. Although this property
can be successfully exploited for expression of toxic
targets [78], it is generally undesirable and generates
false-positive results as the candidate may remain inactive
upon removal of the tag. The importance of the length
and nature of the linker joining the candidate to the fusion
partner has been recognized and discussed in several stud-
ies [79–82], however a systematic study of optimal linker
length has not been carried out for TF-fusion constructs
and will be required to fully exploit its potential as a solu-
bility and co-folding partner in recombinant protein
expression.
Conclusions
Our aim was to develop an efficient screening system
for putatively cold-active enzymes intended for biotech-
nological purposes, using metagenomic DNA from the
marine Arctic environment as a source of candidate
genes. To facilitate this, a vector suite based on the
cspA promoter was designed for fast-cloning and low-
temperature heterologous expression. Our data show that
the cspA promoter can be utilized for low-temperature
production of high levels of expression for putatively cold-
adapted candidate genes. The cspA system also mitigated
the toxic effects that were observed with several candi-
dates under T7-driven expression. We found that combin-
ing the candidate genes with the established MBP fusion
partner substantially improved the solubility of the recom-
binant proteins. We have also extended the utility of the
SUMO protein and TF fusion proteins for soluble protein
production under cspA promoter control. In workflows
typical of an enzyme discovery project, a robust produc-
tion procedure to obtain sufficient quantities of active en-
zyme is typically part of the initial screening phase. From
this perspective, parallel testing of different fusion tags is
extremely useful as it can help improve the efficiency of
the production procedure. In summary, the vector suite
facilitates a low-temperature optimized system for heterol-
ogous expression of putatively cold-active enzymes in
fusion to both small and large fusion partners. The
process of generating all tag-candidate combinations is
simplified by using our parallel cloning strategy for candi-
date gene insertion.
As a proof of concept, we showed that the Arctic-
sourced MZ0009 candidate, a putative GH18 family mem-
ber, was expressed in a soluble and functional form in
the optimized expression system. Recombinant MZ0009
showed activity towards synthetic chitin analogs when cell
Fig. 5 Comparison of expression level, solubility and activity of the
cold-shock inducible, recombinant chitinase. a A representative
SDS-PAGE gel showing the total protein produced (T) and the
soluble fraction (S) in lysed Rosetta2(DE3)pLysS extracts of MZ0009
expressed from the pCold-vector suite. Asterisks indicate the presence
of recombinant proteins of theoretical expected mass (given below
figure). M, Protein standard in kilodaltons (kDa). b Semi-quantitative
calculation of soluble fraction of the MZ0009 fusion proteins. Error bars
show variation in two independent experiments. c Chitinolytic activity,
presented as normalized fluorescence intensities, towards three
synthetic 4-methylumbelliferone-labelled (4MU) chitin analogs in
the cleared lysates containing MZ0009 fused to fusion proteins.
Background activity from expression of ‘empty’ vectors is indicated
with a dashed baseline. A.U., arbitrary units. Error bars show variation in
two replicates in one representative experiment
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lysates with overexpressed fusion proteins were tested in
an activity assay. The highest activity was found for the
4MU-(GlcNAc)3 substrate, indicating that the MZ0009
protein is an endo-chitinase.
We envision this expression system being employed
in further bioprospecting endeavors for psychrophilic
proteins, and suggest that it can provide a good starting
point for enzyme discovery and development. More-
over, the inclusion of His-tag and either TEV or SUMO
protease cleavage sites in all constructs would allow
large-scale purification and tag removal to proceed dir-
ectly from successful screens for crystallization studies.
Finally, we suggest that such a cold-shock inducible
system could be advantageous for the heterologous ex-
pression of toxic mesophilic and thermophilic proteins,
where properties of the proteins are deleterious to the
host cell growth [83, 84]. If such proteins were expressed
at temperatures below their activity optima, we would
expect a decrease in their toxicity during recombinant
production [85].
Additional files
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GH18 chitinases. (JPEG 3038 kb).
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